CLPT
ClearPoint Neuro Inc

3,209
Mkt Cap
$397.64M
Volume
676,600.00
52W High
$30.10
52W Low
$9.76
PE Ratio
-16.93
CLPT Fundamentals
Price
$13.51
Prev Close
$13.99
Open
$14.40
50D MA
$20.09
Beta
1.99
Avg. Volume
938,134.13
EPS (Annual)
-$0.6998
P/B
25.05
Rev/Employee
$272,956.52
Loading...
Loading...
News
all
press releases
ClearPoint Neuro (NASDAQ:CLPT) Cut to Sell at Wall Street Zen
Wall Street Zen cut ClearPoint Neuro from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Lags Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -10.50%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
Pacific Biosciences of California (PACB) Reports Q3 Loss, Lags Revenue Estimates
Pacific Biosciences (PACB) delivered earnings and revenue surprises of +25.00% and -3.51%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
Integra LifeSciences (IART) Q3 Earnings Beat Estimates
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
TransMedics (TMDX) Beats Q3 Earnings Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +78.38% and -0.76%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies
ClearPoint's new Robotic Neuro-Navigation System merges proven software with KUKA robotics to boost precision in cell and gene therapy delivery.
Zacks·2mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue Estimates
ClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -5.00% and -3.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
RxSight (RXST) delivered earnings and revenue surprises of +20.00% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil
Zacks·6mo ago
News Placeholder
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Tops Revenue Estimates
Zacks·6mo ago

Latest CLPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.